Table 1.

Patient data of 430 children who underwent liver transplantation between January 2003 and April 2021 from five centers in Europe.

	Chronic Liver Disease (n = 363)	Control Group/Acute Liver Disease (n = 67)	p
Gender, male (%)	179 (49.3%)	39 (58.2%)	0.181
Diagnosis	BA: 221 (60.9%) Metabolic: 35 (9.6%) PFIC: 25 (6.9%) Cryptogenic cirrhosis: 23 (6.3%) Alagille: 13 (3.6%) CF: 12 (3.3%) Other: 34 (9.3%)	Malignancy: 34 (50.7%) Acute liver failure: 26 (38.8%) Neonatal onset: 6 (9.0%) Amanita phalloides poisoning: 1 (1.5%)
Country distribution of patients	Germany: 163 (44.9%) France: 106 (29.2%) Italy: 84 (23.1%) Lithuania: 10 (2.8%)	Germany: 42 (62.7%) France: 8 (11.9%) Italy: 16 (23.9%) Lithuania: 1 (1.5%)
Age at time of transplant, median (IQR)	1.6 (0.7–4.8)	2.2 (1.3–4.7)	0.314
Year of birth, median (IQR)	2011 (2007–2015)	2011 (2007–2015)	0.849